| 1/3 | US=55 / Biol/Mol Staub M, Eriksson S. The role of deoxycytidine kinase in DNA synthesis and nucleoside analog activation. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 29-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. DESOXICITIDINA-QUINASE; SINTESE DE DNA; ATIVACAO ANALOGO DE NUCLEOSIDEO; DESOXICITIDINA QUINASE; QUINASE DEOXIGUANOSINE; ANALOGOS DESOXINUCLEOSIDOS; DESOXINUCLEOSIDO QUINASE; TIMIDINA QUINASE |
| 2/3 | US=55 / Biol/Mol Hubeek I, Kaspers GJL, Ossenkoppele GJ, Peters GJ. Cytosine arabinoside: metabolism, mechanisms of resistance, and clinical pharmacology. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 119-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. CITOSINA ARABINOSIDO; METABOLISMO; MECANISMOS DE RESISTENCIA; FARMACOLOGIA CLINICA; LEUCEMIA MIELOIDE AGUDA; MODULACAO BIOQUIMICA; CITARABINE ARABINOSIDE; DESOXICITIDINA QUINASE; ALTA DOSE DE ARA-C; FLAG; FLUDARABINA |
| 3/3 | US=55 / Biol/Mol Bergman AM, Peters GJ. Gemcitabine: mechanism of action and resistance. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 225-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. GEMCITABINE; MECANISMO DE ACAO; RESISTENCIA; DESOXICITIDINA QUINASE; REPARO DO DNA; TERMINACAO DA CADEIA MASCARADO; RIBONUCLEOTIDO REDUTASE; AUTO-POTENCIALIZACAO; TIMIDINA QUINASE 2 |